Answers are grounded in this paper and cite their sources.
Key Points Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.
No takes yet. Share an insight, caveat, or question.
Schwab et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: